Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004578097 | SCV005065565 | pathogenic | Pontocerebellar hypoplasia type 1A | 2023-09-14 | criteria provided, single submitter | clinical testing | This variant results in the deletion of part of exon 5 and exons 6-10 (c.318_889+1945delinsTAG) of the VRK1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in VRK1 are known to be pathogenic (PMID: 19646678, 24126608, 27281532). This variant has not been reported in the literature in individuals affected with VRK1-related conditions. ClinVar contains an entry for this variant (Variation ID: 567048). This variant disrupts a region of the VRK1 protein in which other variant(s) (p.His119Arg) have been determined to be pathogenic (PMID: 26583493, 27281532, 31527692). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |